Abl And Odimma Therapeutics Join Forces In Personalized Cancer Immunotherapy
By asianet
ABL Europe (ABL) [https://www.abl-biomanufacturing.com/ ], a pure play contract development and manufacturing organization (CDMO) specialized in development and manufacturing of virus for vaccine candidates, gene and cancer therapies and Odimma Therapeutics (Odimma) [http://odimma-therapeutics.com/?msclkid=8fec39dac63311ec9872f2daaf949638 ] a young biotechnological company focusing on personalized cancer immunotherapy, announced that they have signed a development agreement. ABL will manufacture the … Continued